Here, we confirm high expression of cdks as a feature of NB with unfavorable prognosis and additionally identify CCNB1/cdk1 expression as an MYCN-independent risk factor (Supplementary Figure S1). The gene discussed is MYCN; the disease is neuroblastoma.